IL6 and infection: Prior research supports this possibility: ethacridine lactate in wound models selectively inhibited IL-6 and IL-10 while boosting IL-12 and IFN-γ, effectively skewing the response toward a pro-inflammatory, infection-clearing profile without immunosuppressive effects [17].